(M36.0*) Dermato(poly)myositis in neoplastic disease

Dermato(poly)myositis in neoplastic disease is an autoimmune disorder where the body's own immune system attacks the muscles, causing inflammation and weakness. it is most commonly seen in people with certain types of cancer, such as leukemia, lymphoma, and solid tumors. it is characterized by skin rash, muscle weakness, and elevated levels of certain muscle enzymes. treatment typically involves medications to suppress the immune system and reduce inflammation.

Dermato(poly)myositis in neoplastic disease is an autoimmune disorder in which the body's immune system mistakenly attacks healthy tissue in the skin and muscles. this can lead to inflammation of the skin and muscles, causing pain, weakness, and tenderness. possible causes of the disorder include an underlying malignancy, autoimmune diseases, or certain drugs.

More details coming soon

Main goal of the treatment: To reduce inflammation and improve muscle function.

• Early diagnosis and treatment of the underlying neoplastic disease
• Steroid medications to reduce inflammation
• Immunosuppressant medications to reduce inflammation
• Physical therapy to improve muscle function
• Occupational therapy to improve functional abilities
• Regular exercise to maintain muscle function
• Nutrition therapy to maintain muscle health
• Pain management to reduce pain and discomfort
• Psychological support to cope with the disease

The best way to prevent dermato(poly)myositis in neoplastic disease is to maintain a healthy lifestyle, including regular exercise, a balanced diet, and avoiding smoking and excessive alcohol consumption. additionally, regular medical check-ups and screenings should be done to detect any early signs of the disease.